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Vaccinia immunization was pivotal to successful
smallpox eradication. However, the early immune
responses that distinguish poxvirus immunization
from pathogenic infection remain unknown. To
address this, we developed a strategy to map the
activation of key signaling networks in vivo and
applied this approach to define and compare the
earliest signaling events elicited by immunizing
(vaccinia) and lethal (ectromelia) poxvirus infections
in mice. Vaccinia induced rapid TLR2-dependent
responses, leading to IL-6 production, which then
initiated STAT3 signaling in dendritic and T cells. In
contrast, ectromelia did not induce TLR2 activation,
and profound mouse strain-dependent responses
were observed. In resistant C57BL/6 mice, the
STAT1 and STAT3 pathways were rapidly activated,
whereas in susceptible BALB/c mice, IL-6-depen-
dent STAT3 activation did not occur. These data link
early immune signaling events to infection outcome
and suggest that activation of different pattern-
recognition receptors early after infection may be
important in determining vaccine efficacy.
INTRODUCTION
Successful antiviral immune responses rely on the induction of
a complex cytokine network that activates gene-regulatory
programs across numerous cell populations (Ramshaw et al.,
1997). Many of these immune system-specific programs are
critically dependent on the STAT family of transcription factors,
which is regulated by phosphorylation status (Kisseleva et al.,
2002). In this study, we quantified the in vivo immune response174 Cell Host & Microbe 8, 174–185, August 19, 2010 ª2010 Elsevieat the single-cell level using phosphorylation-specific STAT
monoclonal antibodies (mAbs) and flow cytometry (Krutzik
et al., 2005; Krutzik and Nolan, 2003). We applied this approach
to identify the earliest in vivo immune responses to immunizing or
lethal poxvirus infections and then used mouse genetics and
bioluminescence imaging (BLI) of viral gene expression to inter-
rogate the roles of these events in disease outcome.
Poxviruses are double-stranded DNA viruses (dsDNA) that
usually exhibit strict species tropisms, typically making these
viruses highly pathogenic only in their adapted hosts (Buller
and Palumbo, 1991). Although members of the genus Orthopox-
virus, including human smallpox (variola), mousepox (ectrome-
lia), and vaccinia, are all capable of infecting most mammalian
cells, these closely related viruses demonstrate broad differ-
ences in their pathogenicity at the organismal level (McFadden,
2005). It is likely that the outcome of infection with these viruses
is dependent both on the kinetics and the type of response
induced within cells of the host immune system, as well as by
the ability of the viruses to suppress these responses. Variola
virus, one of the most dangerous pathogens in human history,
was eradicated in the wild through immunization with vaccinia.
The success of this vaccination strategy raises important biolog-
ical and evolutionary questions. Is the evolutionary consequence
of adaptation of a strain to its host one of the pathogen evolving
to evade rapid immune recognition or one of diversion of the
immune system into inappropriate responses? Does the immune
system recognize vaccinia through mechanisms qualitatively
different from variola? Attenuated vaccinia strains have been
developed as recombinant vaccine vehicles (Manrique et al.,
2009; Rodrı´guez et al., 2009), and thus the mechanics by which
the immune system initially responds to non-host-adapted
immunizing versus host-adapted pathogenic poxvirus infections
are of relevance for future vaccine development.
Similar to the case with variola, vaccinia virus immunization
also cross-protects against lethal ectromelia infection in mice
(Fenner, 1949, 1981). Furthermore, ectromelia has increased
pathogenicity in certain mouse strains due to qualitativer Inc.
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2004). To better define the molecular basis for poxvirus species
and strain specificity, we focused on how two poxviruses,
vaccinia and ectromelia, activate the phylogenetically conserved
microbial pattern-recognition receptors of the innate immune
system. Toll-like receptors (TLRs) are the best-characterized
family of pattern-recognition receptors and are expressed
primarily in dendritic cells and macrophages (Beutler et al.,
2007; Koyama et al., 2008). Numerous TLRs have been discov-
ered, and each has specificity for particular microbe-associated
molecular patterns. TLR specificities for lipopeptides (TLR2),
double-stranded RNA (dsRNA, TLR3), lipopolysaccharide (LPS,
TLR4), single-stranded RNA (ssRNA, TLR7), and unmethylated
CpG-containing dsDNA (TLR9) have all been well characterized
(Akira et al., 2006). Recent studies have implicated various
TLRs as necessary for innate recognition of poxviruses (Delaloye
et al., 2009; Samuelsson et al., 2008; Zhu et al., 2007); however,
a systematic comparison of how the immune system initially
responds in vivo to vaccinia versus ectromelia virus infection
has not been performed.
Here, we show that the STAT-signaling networks induced
early during infection by these related poxviruses varied exten-
sively, depending on the virus and/or mouse strain used. Overall,
the kinetics and potency of STAT3 activation directly correlated
with enhanced humoral responses, reduced viral burden, and
survival from lethal infection. Mice susceptible to infection
demonstrated little to no early activation of the STAT networks,
whereas resistant mice experienced potent and rapid STAT
induction. Vaccinia infection induced rapid STAT3 activation,
which was dependent on TLR2 and IL-6. Surprisingly, despite
the important role of these molecules in the earliest immune
response, their genetic absence did not affect viral burden
during initial infection, but instead led to a delayed clearance
of vaccinia and reduction in neutralizing antibody levels. In
contrast to vaccinia, ectromelia detection was independent of
TLR2; however, IL-6 production was essential for surviving
mousepox infection. These data suggest that an important
component in the efficacy of vaccinia in eliciting protective
immune responses relative to the pathogenic nature of smallpox
could be how these viruses activate different pattern-recognition
receptors early after infection. These results could be useful in
the design of improved vaccines or vaccine adjuvants and may
lead to therapeutic approaches to help treat viral infections
soon after exposure.
RESULTS
Examination of the Early STAT Response Network
To evaluate the very earliest STAT-signaling networks induced
during an in vivo immune response, we used single-cell
biochemical analysis of cell populations critical for immunity
(Krutzik et al., 2005; Krutzik and Nolan, 2003). Activation (tyro-
sine phosphorylation) of STATs 1, 3, 4, 5, and 6 was monitored
in conventional dendritic cells (cDCs), CD4+ T cells, CD8+
T cells, B cells, and granulocytes using phosphorylation-specific
mAbs and flow cytometry. Prior to evaluating the complexity of
an intact pathogen, we first focused on reductionist ligands
known to activate specific TLRs. Natural and synthetic ligands
were injected into wild-type C57BL/6 mice to initiate an immuneCell Horesponse. At various time points (from 30min to 24 hr) after injec-
tion, splenic single-cell suspensions were prepared, immediately
fixed in paraformaldehyde, and subjected to intracellular anal-
ysis. Using this method, it was possible to examine the signaling
events induced upon stimulation as they occurred within
different cell subsets within the living animal. The initial peak of
STAT phosphorylation occurred 1 hr following ligand injection.
STAT1 and STAT3 pathway activation was observed in a large
proportion, often greater than half, of splenic cDCs and T cells
(Figure 1A) and at much lower levels in B cells (B220+ CD11c)
and granulocytes (CD11bhi). TLR3, 4, 7, and 9 ligands elicited
both pSTAT1 and pSTAT3 activation, whereas the TLR2 ligands,
the lipoproteins PAM3CSK4 (Pam3CysSerLys4) and FSL1
(Pam2CGDPKHPKSF), activated only the pSTAT3 pathway.
Early pSTAT5 responses were apparent at low frequencies in
cDCs in response to TLR 1/2, 4, and 7 stimulation. pSTAT4
activation at 1 hr was potently induced by TLR7 stimulation in
a subset of CD8+ T cells. STAT6 phosphorylation was observed
at very low levels in B cells in response to LPS. These experi-
ments revealed that STAT activation occurs rapidly and only in
particular cell populations in response to specific stimuli during
the initiation of an in vivo immune response. Next, we sought
to define the molecular basis for these signals both at the
receptor and cytokine level.
Receptor and Cytokine Dependencies of Early STAT
Activation
Although TLRs are accepted as critical for microbial recognition,
distinct mechanisms of pattern recognition exist (Hornung et al.,
2006; Kato et al., 2006). To verify that TLRs were necessary for
the early STAT inductions in vivo, mutant mice lacking specific
functional TLR gene products were injected with ligands known
to activate TLRs 1/2, 3, 4, and 9. Injection of PAM3CSK4, LPS,
and CpG DNA failed to elicit early STAT activation in Tlr2/,
TLR4 mutant, and Tlr9/ mice, respectively (Figure 1B). In
contrast, early STAT phosphorylation was reduced but not totally
eliminated after poly(I:C) treatment of Tlr3/ mice. It is likely
that other dsRNA-specific receptors, such as MDA-5, are
responsible for the rapid poly(I:C) responses induced in the
absence of TLR3 (Gitlin et al., 2006).
The recognition of microbe-associated molecular patterns by
the innate immune system induces the release of a complex set
of cytokines, potentially containing numerous redundant elicitors
of STAT phosphorylation (Adamson et al., 2009; Beutler et al.,
2007). Mice with targeted gene deletions were used to identify
cytokines necessary for early pSTAT1 and pSTAT3 inductions,
since these pathways dominated the early immune response.
Mice lacking the type I IFN receptor (IfnaR/), IFN-g (Ifn-g/),
interleukin-6 (Il-6/), or interleukin-10 (Il-10/) were injected
with LPS, and spleens were harvested 1 hr after intravenous
injection. Early pSTAT1 activation in CD11c+ cells and T cells
was found to be primarily dependent upon type I IFN and to
a lesser extent IFN-g (Figures 1C and S1A). pSTAT3 responses
in the same cell populations were not affected by the absence
of type I IFN or IFN-g signaling.
In Il-6/ mice injected with LPS, pSTAT3 induction was
reduced in cDCs and eliminated in T cells (Figure 1C). The
pattern of pSTAT3 induction in cDCs suggests that other cyto-
kines capable of inducing pSTAT3 are rapidly produced andst & Microbe 8, 174–185, August 19, 2010 ª2010 Elsevier Inc. 175
Cell Host & Microbe
Alternate Mechanisms of Initial Pattern Recognition
176 Cell Host & Microbe 8, 174–185, August 19, 2010 ª2010 Elsevier Inc.
Cell Host & Microbe
Alternate Mechanisms of Initial Pattern Recognitionsensed specifically by a subpopulation of cDCs but not by
T cells. Like IL-6, IL-10 also potently induces STAT3 phosphory-
lation in immune cells (Finbloom andWinestock, 1995); however,
under conditions used here, we found IL-10 to be dispensable for
early STAT3 pathway activation (Figure S1B). Similar results
were obtained when Il-6/ and IfnaR/ mice were treated
with PAM3CSK4, poly(I:C), and CpG DNA (data not shown).
Vaccinia Infection Rapidly Induces
TLR2- and IL-6-Dependent STAT3 Activation
Having established the receptor and cytokine basis for the
major early STAT activation events in response to singular TLR
activation, we next examined a complex microbial stimulus
capable of initiating an antiviral immune response. Vaccinia
virus (Western Reserve strain) was injected intravenously into
C57BL/6 mice, and spleens were harvested at various time
points after infection. Intravenous injection was used to initiate
a synchronous response and to simulate the viremia that occurs
during the natural life cycle of many poxviruses (Moss, 2001).
Since vaccinia is a DNA virus, particular attention was paid to
the patterns and timing of STAT activation elicited by stimulation
of the nucleic acid sensors TLR3 and TLR9 that recognize
ssRNA and dsDNA, respectively (Koyama et al., 2008). Stimula-
tion of these receptors in vivo with synthetic agonists potently
induced both STAT1 and STAT3 phosphorylation in cDCs
(Figure 2A). In contrast, stimulation with the TLR2 agonist,
PAM3CSK4, elicited only pSTAT3 activation. Surprisingly,
systemic vaccinia infection did not typically cause synchronous
pSTAT1 and pSTAT3 activation in cDCs, as would have been
observed if a single nucleic acid-sensing TLR was triggered.
Instead, initial experiments revealed that only pSTAT3 was
induced at 1 hr after vaccinia infection, resulting in a STAT acti-
vation profile resembling TLR2 activation (Figure 2A). Additional
experiments with extended kinetics showed that pSTAT1
responses were induced early but with variability, suggesting
that the elicitors of STAT1 and STAT3 activation were most likely
not produced by a single nucleic acid-sensing TLR. In further
experiments, we evaluated the effects of deletion of B18R,
a vaccinia virulence gene that binds extracellular type I IFN
(Symons et al., 1995), to determine if viral virulence genes
were mediating the unexpectedly low pSTAT1 response to
vaccinia infection. Loss of B18R had minimal effects on pSTAT1
induction (data not shown). In contrast to our findings with
synthetic TLR ligands, we observed the STAT1 response to
vaccinia to be more dependent on IFN-g than on type I IFNsFigure 1. Early In Vivo Response to TLR Ligands Is Characterized by L
Activation in Multiple Cell Types
(A) Relative response to various TLR ligands in different cells as determined by
ligands specific for TLR4 (LPS), TLR9 (CpG), TLR7 (R848), TLR3 (poly[I:C]), TLR1
were intravenously injected into C57BL/6 mice (20 mg/mouse). One hour after
surface marker and pSTAT1, 3, 4, 5, and 6 staining. Cell populations were iden
(B cells), or CD11bhi (granulocytes). The percentage of cells showing greater than
100%).
(B) STAT1 and STAT3 phosphorylation is TLR dependent. Wild-type (green) or T
PAM3CSK4, poly(I:C), LPS, and CpG, respectively. Control PBS treatment is sho
pSTAT1 and pSTAT3 in CD11c+ cells are shown.
(C) STAT1 and STAT3 phosphorylation are type I IFN and IL-6 dependent, respec
were harvested and prepared as before. All experiments were performed in at leas
also Figure S1 for experiments with additional cytokine-deficient mice.
Cell Ho(Figure S3). Nevertheless, in accordance with a previous study
(Mu¨ller et al., 1994), we found both IfnaR/ and Ifn-g/ mice
to be lethally sensitive to viral dosages that are sublethal in
wild-type C57BL/6 mice (data not shown).
The observed pattern of early pSTAT inductions in vivo led us
to hypothesize that TLR2 activation could be the critical early
signaling event induced upon vaccinia infection, with cytosolic
pattern recognition occurring only as a secondary event. To
test this hypothesis, vaccinia virus was injected into Tlr2/
mice (Figure 2B). In Tlr2/ mice, activation of the STAT3
pathway was dramatically reduced (6-fold in dendritic cells)
and peaked 6 hr later than in wild-type mice (Figure S2). Thus,
TLR2 is necessary for robust early pSTAT3 responses in cDCs
and T cells following vaccinia infection, but later responses still
elicit some STAT3 activation.
Since we previously observed that IL-6 was the predominant
cytokine causing STAT3 signaling downstream of TLR2 activa-
tion with lipopeptides, we hypothesized that IL-6 was also the
major driver of STAT3 phosphorylation upon vaccinia infection.
Indeed, injection of vaccinia into Il-6/ mice did not produce
a pSTAT3 response at early time points, demonstrating that
early responses in the STAT3 pathway following infection are
dependent on IL-6 (Figure 2B). As an independent method of
demonstrating that TLR2 engagement is necessary for IL-6
production following infection, serum levels of IL-6 were moni-
tored by ELISA in wild-type and Tlr2/ mice (Figure 2C).
Serum IL-6 increased dramatically 1 hr following vaccinia injec-
tion, and as previously described (Zhu et al., 2007), TLR2 is
required for IL-6 secretion in response to vaccinia infection
in vivo.
To determine whether TLR2 is necessary for vaccinia recogni-
tion in vitro, we employed a cellular assay in which TLR2 was
ectopically expressed in HEK293 cells. Cells were cotransfected
with a luciferase reporter construct driven by an NF-kB-depen-
dent promoter to enable luminescent quantitation of TLR2
activity. Cells that did not express TLR2 were unable to respond
to viral infection or the synthetic TLR2 agonist, PAM3CSK4.
However, in cells expressing TLR2, vaccinia exposure caused
an increase in NF-kB activity similar to that resulting from
PAM3CSK4 treatment (Figure 2D). TLR2 is thus required for acti-
vation and may dimerize with itself or other TLRs to mediate
vaccinia recognition. Taken together, these results are consis-
tent with a model in which TLR2 mediates vaccinia virus recog-
nition, which is necessary for IL-6 release and STAT3 pathway
activation across a variety of immune cells.igand-Specific Type I IFN- and IL-6-Dependent pSTAT1 and pSTAT3
levels of STAT phosphorylation. The indicated natural and synthetic microbial
/2 (PAM3CSK4), TLR2/6 (FSL1), and phosphate-buffered saline (PBS) controls
injection, spleens were harvested and immediately fixed and prepared for
tified as CD11c+ B220 (cDCs); CD4+ T cells; CD8+ T cells; B220+ CD11c
basal STAT phosphorylation is shown as a heat map (black, 0%; bright yellow,
lr2/, Tlr3/, Tlr4 mutant, and Tlr9/ mice (all in blue) were challenged with
wn in red. Spleens were prepared for intracellular staining after 1 hr. Levels of
tively. IfnaR/ and Il-6/ mice were injected with 20 mg LPS; 1 hr later, cells
t three separate mice; data from one representative experiment are shown. See
st & Microbe 8, 174–185, August 19, 2010 ª2010 Elsevier Inc. 177
Figure 2. Systemic Vaccinia Infection Elicits TLR2- and IL-6-Dependent Responses that Promote Viral Clearance and Neutralizing-Antibody
Production
(A) Early in vivo STAT response to vaccinia virus infection resembles the PAM3CSK4 (TLR1/2 ligand) response. pSTAT1 and pSTAT3 activation in CD11c+ cells at
1 hr after intravenous (i.v.) injection with PBS control, CpG, poly(I:C), or PAM3CSK4, compared to vaccinia virus infection (13 107 pfu; Western Reserve strain).
(B) Vaccinia induction of pSTAT3 is TLR2 and IL-6 dependent. Wild-type (green), Tlr2/, or Il-6/ (both in blue) mice were infected with vaccinia virus (VV) as
before, and after 1 hr, spleens were excised, dissociated, and prepared for intracellular analysis. pSTAT3 levels were determined in CD11c+, CD4+, and CD8+
cells.
(C) IL-6 production in response to vaccinia infection is TLR2 dependent. Wild-type and Tlr2/mice were infected i.v. with 13 107 pfu of vaccinia virus. After 1 hr,
serum was harvested for detection of secreted IL-6 by ELISA. Serum from uninfected mice was used as control (data represented as mean ±SD).
(D) Vaccinia is recognized by TLR2 in vitro. HEK293 cells transfected with mouse TLR2 and an NF-kB-driven luciferase reporter and untransfected control cells
with the NF-kB-driven luciferase reporter alone were exposed to UV-inactivated vaccinia virus (five viral particles per cell). At 24 hr, NF-kB-driven luciferase
expression was evaluated by bioluminescence after addition of luciferase (data represented as mean ±SD). See also Figure S2 for a time course of pSTAT3 acti-
vation in Tlr2/ mice.
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Mice
Our pathway analyses clearly demonstrated the molecular basis
for STAT3 activation during an early antiviral immune response.
Nevertheless, it was still possible that TLR2 and IL-6 responses
were not physiologically important and were dispensable for178 Cell Host & Microbe 8, 174–185, August 19, 2010 ª2010 Elseviethe control of virus replication. Using in vivo bioluminescence
imaging (BLI) of mice infected with a luciferase-expressing
vaccinia virus, we quantified viral gene expression levels, which
are known to correlate directly with viral burden (Luker et al.,
2005), daily for 15 days following infection. Unexpectedly, viral
burden was increased in Tlr2/ and Il-6/ mice relative tor Inc.
Figure 3. Robust Long-Term Immune Response to Vaccinia Is Dependent on Early TLR2 and IL-6 Signaling
(A) Tlr2/ or Il-6/ mice display delayed clearance of vaccinia virus. Mice (wild-type, Tlr2/, or Il-6/ of the C57BL/6 background) were infected i.v. with 13
107 pfu of Western Reserve strain vaccinia expressing luciferase. Overall viral load was determined at different times by bioluminescence imaging (BLI) after lucif-
erin substrate delivery by intraperitoneal injection in an IVIS 200 (Xenogen). No differences were seen in initial overall viral gene expression (correlating with viral
replication) or biodistribution (except that an early spleen signal seen in C57BL/6 mice was absent from the gene knockout strains). Significant differences were
not seen until 6 days after infection, when the gene knockout strains displayed delayed viral clearance (data represented asmean ±SD,with n = at least threemice
per group).
(B) Addition of exogenous IL-6 can substitute for loss of TLR2. C57BL/6, Tlr2/, and Il-6/mice were infected with vaccinia expressing luciferase as before; in
one group, Tlr2/ mice were additionally treated with 500 ng IL-6 delivered intraperitoneally. Viral luciferase gene expression is shown for whole animals as
determined 7 days postinfection (data represented as mean ±SD, with n = at least three mice per group).
(C) Loss of TLR2-IL-6-pSTAT3 early signaling pathway leads to reduced levels of anti-vaccinia neutralizing antibody. Mice treated as above were sacrificed
21 days after initial viral infection, and levels of vaccinia-specific antibody in the serum were determined with a viral neutralization assay. The Tlr2/ and
Il-6/ strains both displayed reduced levels of neutralizing antibody.
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(Figure 3A). This suggests that although IL-6 is produced within
the first hour of infection, it may primarily promote later adaptive
antiviral immune responses. Importantly, injection of recombi-
nant IL-6 alone was sufficient to induce the pSTAT3 pathway
in vivo (data not shown), and a single dose of IL-6 rescued anti-
viral immunity in Tlr2/mice, as measured by viral gene expres-
sion 7 days after infection (Figure 3B).
The ability of IL-6 to promote antibody production is well
established (Kopf et al., 1994, 1998; Suematsu et al., 1989).
IL-6 has been previously shown to enhance humoral immune
responses against vaccinia (Ramsay et al., 1994); however, it
has not previously been shown that early TLR2-dependent
recognition can influence antibody production. We therefore
monitored circulating anti-vaccinia antibody levels using a virus
neutralization assay. Serum from infected Il-6/ and Tlr2/
mice had approximately 5-fold less neutralizing activity than
wild-type controls (Figure 3C), indicating that early TLR2-depen-
dent IL-6 production enhanced vaccinia-specific humoralCell Horesponses and clearance of the viral infection. This is in agree-
ment with a recent study demonstrating that recombinant IL-6
injected early during influenza infection causes increased influ-
enza-specific IgM and IgG1 production (Dienz et al., 2009).
Differences in Early Immune Recognition between
Poxviruses
Orthopoxviruses are often capable of infecting cells from
numerous mammalian species in vitro but display strict species
specificity on the organismal level (McFadden, 2005). Vaccinia is
capable of infecting many cell types in vitro and in vivo and
induces a robust immunization in mice without causing disease;
in contrast, ectromelia, a closely related virus, is highly patho-
genic inmice, its cognate host (Buller and Palumbo, 1991). Using
our single-cell approach, differences in immune recognition of
related poxviruses were monitored. In C57BL/6 mice, vaccinia
infection induced pSTAT1 and pSTAT3 activation in cDCs and
T cells more rapidly than did ectromelia infection (Figure 4A).
Furthermore, the percentage of cells displaying STAT3 activationst & Microbe 8, 174–185, August 19, 2010 ª2010 Elsevier Inc. 179
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Figure 4. Resistance to Poxvirus Infection Correlates with Early and Potent STAT Network Activation in Dendritic Cells and T Cells
(A) Ectromelia virus infection produces delayed and reduced pSTAT1 and pSTAT3 induction, especially in sensitive BALB/c mice. In vivo time course of the early
immune responses in C57BL/6 and BALB/c mice infected intravenously with 1 3 107 pfu of either vaccinia virus or ectromelia virus (Moscow strain) was deter-
mined as in Figure 1. Percentage of cells demonstrating pSTAT1 or pSTAT3 activation at different times after infection is plotted for conventional dendritic cells
(CD11c+), T cells (CD4+ or CD8+), B cells (B220+), and granulocytes (CD11bhi) (data represented as mean ±SD).
(B) Ectromelia virus induction of pSTAT3 is IL-6 but not TLR2 dependent. Wild-type (C57BL/6), Tlr2/, and Il-6/mice were infected with 13 107 pfu ectromelia
virus. After 1 hr, spleens were excised, dissociated, and prepared for intracellular analysis. Levels of pSTAT3 in CD11c+ cells are shown (data represented as
mean ±SD; two-tailed, unpaired t test: *p < 0.02 for Il-6/ compared to WT and Tlr2/, WT compared to Tlr2/ was not significant).
(C) Vaccinia presents a far more potent TLR2 ligand than ectromelia. HEK293 cells transfected with mouse TLR2 and an NF-kB-driven luciferase reporter and
untransfected control cells with the NF-kB-driven luciferase reporter alone were exposed to UV-inactivated vaccinia virus or ectromelia virus (five viral particles
per cell). NF-kB-driven luciferase expression evaluated by bioluminescence signal (after addition of luciferase) was determined 24 hr later (data represented as
mean ±SD).
(D) TLR2 is dispensable for resistance to ectromelia virus infection in C57BL/6 mice. Wild-type and Tlr2/ mice of the C57BL/6 background were intravenously
infected with 1 3 105 pfu of ectromelia virus. Survival was monitored for 10 days following infection. See also Figure S3 for vaccinia infection of Ifn/ mice.
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after ectromelia infection in multiple cell types. However, at
3 hr, the percentage of cells with phosphorylated STAT1 was
comparable between the two viruses. The pSTAT3 activation
induced by ectromelia infection was not significantly dependent
on TLR2 but was IL-6 dependent (Figure 4B), indicating that
vaccinia and ectromelia engage different pattern-recognition
receptors early during infection. In further support of this notion,
ectromelia had far less stimulatory activity than vaccinia in
in vitro HEK293 based TLR2 reporter assays (Figure 4C). As
expected based on the results of this in vitro assay, wild-type
and Tlr2/micewere equally susceptible to ectromelia infection
in survival studies, and Tlr2/ mice did not exhibit a significant
increase in viral burden (Figure 4D and data not shown). These
results suggest that TLR2 is dispensable for resistance to lethal
ectromelia infection.
We sought to compare serum ELISA levels of IL-6 between
vaccinia- and ectromelia-infected mice; however, increased
levels of IL-6 could not be detected in the serum of ectromelia-
infected mice (data not shown). It is possible that pSTAT3 moni-
toring in dendritic cells may be a more sensitive method than
serum ELISA for detecting minor increases in IL-6 production
in vivo.
IL-6 Is an Essential Resistance Factor
in the Pathogenesis of Ectromelia
Ectromelia virus demonstrates increased pathogenicity and
lethality in specific strains ofmice; the C57BL/6 strain is relatively
resistant, and the BALB/c strain is extremely sensitive (Wallace
et al., 1985).We hypothesized that differences in early STAT acti-
vation could underliemechanisms of host resistance to ectrome-
lia in C57BL/6 mice. Strikingly, ectromelia infection of BALB/c
mice yielded only slight activation of pSTAT1 and no pSTAT3
response in the cell populations we analyzed (Figure 4A). Impor-
tantly, no differences were observed in the activation of these
pathways between C57BL/6 mice and BALB/c mice after
vaccinia infection (data not shown).
IL-6-dependent STAT3 activation occurs within 3 hr of
systemic ectromelia infection in C57BL/6 mice. To establish
whether C57BL/6 mice genetically lacking IL-6 demonstrate
increased susceptibility to infection, wild-type and Il-6/ mice
were infected with 1 3 103 plaque-forming units (pfu) of
ectromelia, and survival was monitored for 20 days following
infection. All Il-6/ mice succumbed to infection by 13 days
postinfection, whereas all wild-type mice survived (Figure 5A).
In addition, Il-6/ mice carried a higher viral burden, in liver,
compared to wild-type controls (Figure 5A). These experiments
demonstrate that IL-6 is an important resistance factor essential
for surviving ectromelia infection.
TLR2 Activation Prior to Ectromelia Infection Reduces
Viral Burden
Therapeutic vaccination with an attenuated vaccinia strain
(modified vaccinia Ankara [MVA]) protects ectromelia-chal-
lenged mice from an otherwise lethal infection even if adminis-
tered days after ectromelia inoculation (Samuelsson et al.,
2008). Surprisingly, TLR9 stimulation by MVA DNA is dispens-
able for protection since therapeutic vaccination is also
observed in lethally infected Tlr9/ mice. We considered theCell Hopossibility that the therapeutic effects of MVA pretreatment are
mediated by TLR2 activation. Similar to vaccinia infection, we
found that MVA immunization induces potent pSTAT3 activation
in dendritic cells and T cells (data not shown). Therefore, to eval-
uate whether TLR2 activation alone could reduce viral burden,
20 mg of PAM3CSK4 was injected into C57BL/6 mice 1 hr prior
to ectromelia infection. Both MVA and PAM3CSK4 pretreatment
significantly reduced ectromelia burden in the spleen at 72 hr
following infection (Figure 5B). In contrast, ectromelia burden
was not reduced by PAM3CSK4 pretreatment in Il-6/ mice
(Figure 5C), substantiating the importance of IL-6 in mediating
resistance to ectromelia. Unexpectedly, TLR2 activation with
the purified ligand PAM3CSK4 was more effective than immuni-
zation with attenuated virus in lowering ectromelia viral burden in
both spleen and liver, suggesting that therapeutic vaccination of
poxvirus infection could be performed with TLR agonists instead
of intact viral particles.
DISCUSSION
The recognition of pathogen-associated molecular patterns
(PAMPs) occurs during the earliest steps of an innate immune
response. Pattern recognition causes the release of numerous
cytokines capable of initiating gene-regulatory programs
through the activation of transcription factor networks. Until
now, it has been impossible to examine how this transcription
factor network is activated in response to a microbial infection
in the context of an intact immune system, within a living host.
Direct measurement of serum cytokines in vivo demonstrates
the presence of specific interleukins but does not reveal which
immune cells actually respond to a particular cytokine. Because
of this, our current understanding of cytokine responsiveness is
based largely on in vitro experiments in which bone marrow-
derived or sorted primary cells are treated with recombinant
cytokines and then subjected to western blot analysis. In vivo
cytokine responsiveness may differ drastically from the in vitro
responsiveness of cellular monocultures due to competition
between different cell types for available cytokines (Pandiyan
et al., 2007), as well as biophysical constraints imposed by
the stromal microarchitecture of secondary lymphoid organs
(Gretz et al., 2000). Here, we have developed a strategy to study
the kinetics and levels of activation of different signaling path-
ways within diverse immune cell populations at times after
exposure to a pathogen. This approach allowed us to define
the earliest STAT-signaling pathways induced by different
(immunizing or pathogenic) poxviruses in the context of a living
organism and to correlate network activation with different
immune outcomes.
Vaccinia was key to what is possibly mankind’s greatest
medical achievement, the eradication of smallpox. Attenuated
and wild-type vaccinia strains continue to be evaluated clinically
as recombinant vaccine vehicles for a number of infectious
agents, including HIV (Manrique et al., 2009; Rodrı´guez et al.,
2009). Deeper comprehension of the immune response to
vaccinia may produce strategies to enhance vaccine efficacy
and predict potentially harmful side effects, while an under-
standing of how the early immune response differs in vaccinating
and pathogenic infections may lead to alternative therapeutic
approaches to predict the outcome of infection.st & Microbe 8, 174–185, August 19, 2010 ª2010 Elsevier Inc. 181
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Figure 5. IL-6 Induction Is Necessary for Resistance to Ectromelia Virus Infection in C57BL/6 Mice
(A) Wild-type and Il-6/mice of the C57BL/6 background were subcutaneously infected with 13 103 pfu of ectromelia virus. Survival was monitored for 20 days
following infection. Livers were extracted from separate groups of infected mice on day 7, and a plaque-forming assay was used to monitor viral burden.
(B) TLR2 activation prior to ectromelia infection reduces viral burden. PBS, 1 3 107 pfu of MVA (modified vaccinia Ankara), or 20 mg of PAM3CSK4 was intrave-
nously injected into C57BL/6 mice 1 hr before systemic infection with 1 3 107 pfu of ectromelia. Spleens were excised 72 hr later, and ectromelia burden was
quantified using a plaque-forming assay (data represented as mean ±SD; two-tailed, unpaired t test: *p < 0.01 MVA compared to PBS, p < 0.007 PAM3CSK4
compared to PBS).
(C) PAM3CSK4 pretreatment does not reduce ectromelia burden in Il-6/ mice. PBS or 20 mg of PAM3CSK4 was intravenously injected into C57BL/6 Il-6/
mice 1 hr before systemic infectionwith 13 107 pfu of ectromelia. Spleens were excised 48 hr later, and ectromelia burdenwas quantified using a plaque-forming
assay (data represented as mean ±SD).
Cell Host & Microbe
Alternate Mechanisms of Initial Pattern RecognitionA number of innate and adaptive cell populations have been
linked to protective responses against orthopoxviruses (Xu
et al., 2004). Innate immunity is thought to be highly dependent
upon type I IFN-activated natural killer cells (Martinez et al.,
2008) and gd T cells (Selin et al., 2001). Adaptive CD8+ T cell
responses are often critical for destruction of virally infected
cells; however, only a minor role for CD8+ T cell-mediated
cellular immunity has been described for resistance against
vaccinia infection (Spriggs et al., 1992; Xu et al., 2004). In
contrast, humoral immune responses are known to be important
in controlling vaccinia in both humans (Lane et al., 1969) and
mice (Galmiche et al., 1999). In mice depleted of either CD4+
T cells or B cells, severe defects in neutralizing antibody produc-
tion are associated with enhanced viral replication. These
studies revealed the CD4+ T cell dependence of a large portion
of the anti-vaccinia neutralizing antibody response.
Here, we demonstrate how vaccinia infection induces immune
network signals that promote humoral immunity. Early IL-6
production, preferential activation of the STAT3 pathway, and
potent neutralizing antibody responses all depended on viral182 Cell Host & Microbe 8, 174–185, August 19, 2010 ª2010 Elsevierecognition via TLR2. We found that IL-6 was necessary for
robust activation of the STAT3 pathway, although numerous
cytokines can potentially activate STAT3 in T cells (including
IL-10 and IL-21). IL-6 is thus a nonredundant regulator of
STAT3 programming, with reported effects ranging from
increased T cell viability (Takeda et al., 1998) to the deactivation
of regulatory T cells (Korn et al., 2007) and, prominently, the
promotion of antibody responses.
Surprisingly, although IL-6 was first discovered as a B cell
hybridoma factor (Hirano et al., 1985), in our experiments, naive
B cells were only minimally sensitive to IL-6 in vivo at times early
after exposure to vaccinia (Figure 4A). Our observation is in
agreement with a recent study that suggests that B cells are
indirectly affected by IL-6 through the IL-6-dependent genera-
tion of IL-21-producing T follicular helper (TFH) cells (Dienz
et al., 2009). Alternatively, B cell receptor stimulation increases
IL-6Ra expression (Burdin et al., 1996); thus, B cells most likely
achieve robust STAT3 activation indirectly through IL-21
produced by TFH cells or via IL-6 directly only after antigen
recognition.r Inc.
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Alternate Mechanisms of Initial Pattern RecognitionIn the ectromelia model, at least two lines of evidence indicate
that the early induction of IL-6-dependent pSTAT3 can signifi-
cantly impact on the outcome of infection. First, pSTAT3 is
induced rapidly in resistant C57BL/6 mice, whereas in the
susceptible strain, it is not. Second, C57BL/6 mice deficient in
IL-6 are highly susceptible to infection. Although the precise
molecular mechanism(s) through which IL-6-dependent pSTAT3
induction restricts ectromelia replication is not yet known, our
data suggest it acts early and may likely have a role in the innate
and inflammatory responses. This is because the absence of
IL-6 does not affect generation of a robust antiviral cytotoxic
T cell response (data not shown), and Il-6/ mice succumb
to mousepox significantly earlier than B cell-deficient mice
(Chaudhri et al., 2006). Nevertheless, it is likely that IL-6 plays
an important role early during the innate response and later in
generation of anti-ectromelia antibody responses.
A recent study has shown that TLR9 recognition of ectromelia
is necessary for IL-6 production by dendritic cells in vitro
(Samuelsson et al., 2008). It is therefore probable that TLR9
sensing is also responsible for IL-6 production and STAT activa-
tion in our in vivo model. Additionally, cytosolic recognition of
vaccinia DNA is most likely responsible for the IL-6 production
observed later in infection in the absence of TLR2 (Figure S2).
These results suggest that a fundamental difference exists in
the initial immune response to these closely related poxviruses:
vaccinia immediately triggers TLR2 and eventually activates
microbial nucleic acid-sensing receptors, whereas ectromelia
evades TLR2 recognition and is only recognized later by nucleic
acid sensors such as TLR9. If this initial IL-6 response to ectro-
melia in vivo is purely TLR9 dependent, then the mechanism
for TLR9 evasion by ectromelia in BALB/c mice demands further
investigation. This fundamental difference in the early host
response to vaccinia versus ectromelia may be a key determi-
nant in the maintenance of host-species specificity and could
underlie the unique and potent immunogenicity of vaccinia virus.
The single-cell approach to determining the status of signaling
pathways utilized in this study facilitated the in vivo deconstruc-
tion of the antiviral cytokine response network subsequent to
poxvirus infection. Furthermore, we found early and robust
STAT1 and STAT3 pathway activation was directly correlated
with positive long-term immune outcomes. As single-cell bio-
chemical analysis advances, it will be possible to simultaneously
interrogate the activation states of all critical immune signaling
pathways across the entire spectrum of hematopoietic cell
populations. Definitive in vivo network maps revealing how
cytokines program the immune system during homeostasis
and disease are the likely byproduct of evaluating the immune
system cell by cell and may provide means to develop
therapeutic approaches, to closely assess an ongoing immune
response, and to predict immune outcome.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6J, BALB/c, B6;129, Tlr2/, Tlr3/, Tlr4lps-del, Ifn-g/, Il-6/,
and Il-10/ mice were purchased from Jackson Laboratory (Bar Harbor,
ME). IfnaR/ mice were a gift from Denise Monack (Stanford University)
and Hideho Okada (University of Pittsburgh). Tlr9/mice were a gift from Shi-
zuo Akira (Osaka University). All mice were bred andmaintained in accordance
with the guidelines of the Local Administrative Panels on Laboratory AnimalCell HoCare/Institutional Animal Care and Use Committee protocols. All mice used
were between 6 and 8 weeks of age and were also strain and gender matched
within experiments.
In Vivo Innate Immune Stimulation with TLR Ligands
Purified LPS (from E. coli K12), ODN1826 (CpG), R848 (resiquimod), poly(I:C),
PAM3CSK4, and FSL1 were purchased from Invivogen (San Diego, CA). Mice
were injected via the tail vein with 20 mg of each ligand. Following stimulation
in vivo, the spleens of recipient mice were harvested as previously described
(Krutzik et al., 2005). In brief, mice were sacrificed at various time points
between 15 min and 7 hr after stimulation. Spleens were excised and immedi-
ately dissociated into a 10ml PBS solution containing 1.6% paraformaldehyde
(Electron Microscopy Sciences; Hatfield, PA). Following a 15 min fixation
period, cell suspensions were transferred through a 70 mm pore-size mesh,
and ice-cold methanol was directly added to a final concentration of 80%
methanol. In some experiments, mice were injected with 2–15 mg of ligand.
Staining and Flow Cytometry
Fixed and permeabilized cells were prepared for intracellular analysis as previ-
ously described (Krutzik et al., 2005; Krutzik and Nolan 2003). The following
Abs were used in eight-color panels (in parallel) to identify and analyze splenic
cell populations (purchased from BD Biosciences [Franklin Lakes, NJ] except
as noted): pSTAT1 (pY701, clone 4a), pSTAT3 (pY705, clone 4), pSTAT4
(pY693, clone 38), pSTAT5 (pY694, clone 47), pSTAT6 (pY641, clone J71-
773.58.11), B220 (RA3-6B2), CD90.2 (BioLegend [San Diego, CA]; 30-H12),
CD4 (RM4-5), CD11b (M1/70), CD11c (HL3), and anti-keyhole limpet hemocy-
anin control antibody (X40). All antibody concentrations were titrated for
optimal staining in a 100 ml staining volume with no more than 4 3 106 meth-
anol-permeabilized cells per sample. The percent pSTAT positivity represents
the percentage of activated cells showing a pSTATmedian fluorescence inten-
sity greater than the highest 1% of that of PBS controls.
Viral Infection
Vaccinia strain Western Reserve was purchased from ATCC (Manassas, VA).
TheWestern Reserve strain expressing luciferase was kindly provided by Gary
Luker (University of Michigan) and the ectromelia virus (Moscow strain) was
kindly provided by Mark Buller (St. Louis University). Purified viral preparations
were delivered via tail vein injection at 1 3 107 pfu/mouse unless otherwise
stated. In some experiments, the virus was filter sterilized (to remove viral parti-
cles) and used as a control to verify that no contaminants from the viral prep-
aration were activating TLRs. Mice were sacrificed, and tissues were collected
for determination of activation of signaling pathways by flow cytometry or viral
load by plaque assay. Alternatively, BLI was performed to determine levels of
viral luciferase gene expression. Mice were injected intraperitoneally (i.p.) with
luciferin (300 mg/kg), anesthetized (2% isoflurane), and imaged in an IVIS 200
(Xenogen/Caliper Life Sciences; Hopkinton, MA).
Serum Cytokine Measurements by ELISA
Production of IL-6 in vivo in response to viral infection was detected in sera by
ELISA kits purchased from R&D (Minneapolis, MN) according to manufac-
turer’s protocols.
Neutralizing Antibody Quantification
A standard neutralizing antibody assay was performed. Briefly, serial dilutions
of heat-inactivated plasma samples were mixed with 1 3 103 pfu of vaccinia
strain Western Reserve expressing luciferase, and neutralization was allowed
to occur for 2 hr. Virus and plasma were then layered over a monolayer of
A2780 cells (from ATCC), and infection and viral gene expression were allowed
to take place for 24 hr. At the end of this time, the level of nonneutralized virus
was determined by BLI (IVIS 200, Xenogen). The relative percentage neutrali-
zation was determined relative to virus with no plasma (0% neutralization) and
plasma with no virus (100% neutralization). Levels of neutralizing antibody
were defined by the dilution of plasma required to achieve 50% neutralization
of the virus.
In Vitro TLR2 Activation Assay
HEK293 cells and HEK293 cells stably transfected to express murine TLR2
were purchased from Invivogen. These cells were transiently transfectedst & Microbe 8, 174–185, August 19, 2010 ª2010 Elsevier Inc. 183
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Alternate Mechanisms of Initial Pattern Recognitionwith the pNIFTY plasmid (Invivogen) containing a luciferase reporter driven by
an NF-kB-responsive promoter. These cells were exposed to control ligands
or UV-inactivated vaccinia virus (moi of five viral particles per cell). Luciferase
expression was determined at indicated times after stimulation by BLI (IVIS
200, Xenogen, part of Caliper) subsequent to addition of luciferin.
Statistical Analysis
A two-tailed, unpaired t test analysis was used in some experiments to deter-
mine significance for averaged values with noted standard deviations. At least
three mice per group and often as many as seven mice per group were
analyzed.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and can be found with this
article online at doi:10.1016/j.chom.2010.07.008.
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